News >

Novel Agents, Approaches Advancing CLL Paradigm

Jessica Hergert
Published: Monday, Feb 03, 2020

Farrukh T. Awan, MD, an associate professor in the Department of Internal Medicine at UT Southwestern Medical Center

Farrukh T. Awan, MD
There has been an explosion of new therapeutics that have become available in the paradigm of chronic lymphocytic leukemia (CLL), such as next-generation BTK inhibitors, explained Farrukh Awan, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication